3 There is some evidence that GLP-1 affects glucose utilization by directly stimulating glycogen synthesis in both rat skeletal muscle 4 and rat adipose tissue 5 , at the same time causing an increase in glycogen synthase-alpha
Most patients experience diarrhea for 26 weeks after starting semaglutide, with the highest frequency during dose increases
The GIP/GLP-1-receptor agonist tirzepatide was approved for the treatment of T2D by the Food and Drug Administration (FDA) in the USA for once-weekly subcutaneous injections in May 2022 and has just received a positive opinion from the European Medicines Agency (EMA)
A Tense Supply Chain, an Evolving FDA The FDAs actions have been met with market and legal protest, with advocates and companies alleging overreach through lawsuits
Neither Atlanta Innovative Medicine nor its physician affiliates promise regenerative therapies as a cure for any condition, disease, or injury
Epstein Barr Virus Volume 1: One Herpes Virus: Many Dis